Atria Investments’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.43M Sell
106,265
-18,236
-15% -$1.27M 0.09% 265
2025
Q1
$9.15M Buy
124,501
+20,813
+20% +$1.53M 0.12% 202
2024
Q4
$6.79M Sell
103,688
-3,180
-3% -$208K 0.08% 269
2024
Q3
$8.33M Buy
106,868
+9,431
+10% +$735K 0.1% 224
2024
Q2
$7.6M Buy
97,437
+12,182
+14% +$950K 0.1% 234
2024
Q1
$5.78M Buy
85,255
+629
+0.7% +$42.6K 0.08% 300
2023
Q4
$5.7M Buy
84,626
+5,078
+6% +$342K 0.09% 265
2023
Q3
$5.39M Buy
79,548
+8,044
+11% +$545K 0.1% 266
2023
Q2
$5.12M Sell
71,504
-7,973
-10% -$571K 0.09% 260
2023
Q1
$5.52M Buy
79,477
+4,532
+6% +$315K 0.1% 234
2022
Q4
$5.08M Sell
74,945
-1,878
-2% -$127K 0.1% 253
2022
Q3
$4.21M Buy
76,823
+14,905
+24% +$817K 0.09% 269
2022
Q2
$4.09M Sell
61,918
-16,080
-21% -$1.06M 0.09% 286
2022
Q1
$5.17M Sell
77,998
-1,210
-2% -$80.3K 0.09% 275
2021
Q4
$4.61M Buy
79,208
+3,329
+4% +$194K 0.08% 303
2021
Q3
$4.56M Buy
75,879
+21,206
+39% +$1.27M 0.08% 281
2021
Q2
$3.28M Buy
54,673
+10,526
+24% +$631K 0.06% 350
2021
Q1
$2.2M Sell
44,147
-2,794
-6% -$139K 0.05% 422
2020
Q4
$2.35M Buy
46,941
+5,329
+13% +$266K 0.06% 377
2020
Q3
$2.28M Sell
41,612
-1,333
-3% -$73K 0.07% 306
2020
Q2
$2.27M Buy
42,945
+5,628
+15% +$298K 0.08% 278
2020
Q1
$1.67M Buy
37,317
+8,867
+31% +$396K 0.13% 159
2019
Q4
$1.42M Buy
+28,450
New +$1.42M 0.04% 417
2019
Q3
Sell
-13,857
Closed -$616K 864
2019
Q2
$616K Sell
13,857
-1,091
-7% -$48.5K 0.02% 523
2019
Q1
$595K Sell
14,948
-1,291
-8% -$51.4K 0.03% 489
2018
Q4
$617K Sell
16,239
-7,567
-32% -$288K 0.03% 433
2018
Q3
$942K Sell
23,806
-8,278
-26% -$328K 0.04% 413
2018
Q2
$1.13M Sell
32,084
-4,494
-12% -$158K 0.05% 348
2018
Q1
$1.28M Buy
36,578
+3,083
+9% +$108K 0.06% 292
2017
Q4
$1.16M Buy
33,495
+6,979
+26% +$242K 0.06% 302
2017
Q3
$898K Buy
26,516
+1,821
+7% +$61.7K 0.05% 331
2017
Q2
$842K Buy
24,695
+129
+0.5% +$4.4K 0.05% 324
2017
Q1
$765K Buy
24,566
+2,521
+11% +$78.5K 0.05% 307
2016
Q4
$602K Buy
22,045
+11,437
+108% +$312K 0.05% 307
2016
Q3
$349K Buy
+10,608
New +$349K 0.03% 373